Date published: 2026-11-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

JNK1/2 Antibody (D-9): sc-137019

5.0(2)
Write a reviewAsk a question
Datasheets
  • JNK1/2 Antibody (D-9) is a mouse monoclonal IgG2b κ, cited in 32 publications, provided at 200 µg/ml
  • raised against amino acids 1-384 representing full length JNK1 p461 p46 of human origin
  • recommended for detection of JNK1 and JNK2 p46 and p54 isoforms of mouse, rat and human origin by WB, IP, IF and ELISA
  • See JNK (D-2): sc-7345 for JNK1/2 antibody conjugates, including AC, HRP, FITC, PE, Alexa Fluor® 488, 594, 647, 680 and 790.
  • m-IgG2b BP-HRP is the preferred secondary detection reagent for JNK1/2 Antibody (D-9) for WB applications. This reagent is now offered in a bundle with JNK1/2 Antibody (D-9) (see ordering information below).
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

JNK1/2 Antibody (D-9) is a mouse monoclonal IgG2b kappa light chain antibody raised against full-length human JNK1 p46 (amino acids 1-384), a stress-activated protein kinase essential for cellular stress responses. JNK1/2 mouse monoclonal antibody (D-9) recognizes both JNK1 and JNK2 isoforms and demonstrates broad species cross-reactivity, detecting p46 and p54 variants in mouse, rat, and human samples through Western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) applications. JNK1 and JNK2 demonstrate remarkably context-dependent functions in disease, particularly in cancer biology. For example, JNK1 acts as a tumor promoter in hepatocellular carcinoma by enhancing cell growth and proliferation, yet surprisingly functions as a tumor suppressor in skin cancers. Similarly, JNK2 exhibits oncogenic properties across multiple cancer types, including myeloma, lung, and skin cancers, where JNK2 supports cancer cell survival. These diverse effects stem from JNK1/2′s participation in sophisticated protein interaction networks. Both kinases form regulatory complexes with key signaling proteins such as c-Jun, p53, and Bcl-2, thereby modulating critical cellular processes including apoptosis and inflammation. Through these interactions, JNK1/2 influence various transcription factors, most notably AP-1, creating intricate signaling cascades that control multiple cellular behaviors. When these finely balanced pathways become dysregulated, they can contribute to a spectrum of pathological conditions beyond cancer, including immune disorders and neurodegenerative diseases. Through these context-specific functions and complex interaction networks, JNK1/2 (D-9) antibody serves as a valuable tool for investigating disease mechanisms and developing targeted therapeutic strategies.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.

Download thiomersal SDS

JNK1/2 Antibody (D-9) References:

  1. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.  |  Oleinik, NV., et al. 2007. Oncogene. 26: 7222-30. PMID: 17525747
  2. JNK1 and JNK2 differently regulate IL-12 production in THP-1 macrophage cells.  |  Utsugi, M., et al. 2010. Cytokine. 51: 127-31. PMID: 20483637
  3. JNK1/2 regulates ER-mitochondrial Ca2+ cross-talk during IL-1β-mediated cell death in RINm5F and human primary β-cells.  |  Verma, G., et al. 2013. Mol Biol Cell. 24: 2058-71. PMID: 23615449
  4. JNK1 and JNK2 regulate α-SMA in hepatic stellate cells during CCl4 -induced fibrosis in the rat liver.  |  Hong, IH., et al. 2013. Pathol Int. 63: 483-91. PMID: 24134609
  5. JNK1/2 expression and modulation of STAT3 signaling in oral cancer.  |  Gkouveris, I., et al. 2016. Oncol Lett. 12: 699-706. PMID: 27347203
  6. JNK1/2 and ERK1/2 provides vital clues about tumor recurrence and survival in hepatocellular carcinoma patients.  |  Gao, X., et al. 2018. Future Oncol. 14: 2471-2481. PMID: 29714074
  7. Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation.  |  Günther, JK., et al. 2020. Biology (Basel). 9: PMID: 32429320
  8. Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway.  |  Mo, J., et al. 2022. Evid Based Complement Alternat Med. 2022: 7861338. PMID: 35341136
  9. The Involvement of Cx43 in JNK1/2-Mediated Endothelial Mechanotransduction and Human Plaque Progression.  |  Tauchi, M., et al. 2023. Int J Mol Sci. 24: PMID: 36674690
  10. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling.  |  Cheng, Y., et al. 2023. Phytomedicine. 114: 154757. PMID: 37011418
  11. LCZ696 attenuates sepsis-induced liver dysfunction in rats; the role of oxidative stress, apoptosis, and JNK1/2-P38 signaling pathways.  |  Mohyeldin, RH., et al. 2023. Life Sci. 334: 122210. PMID: 37883863

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

JNK1/2 Antibody (D-9)

sc-137019
200 µg/ml
$322.00

JNK1/2 Antibody (D-9): m-IgG2b BP-HRP Bundle

sc-548499
200 µg Ab; 10 µg BP
$361.00

For Western Blot, is it recommended to use denatured or non-denatured conditions with JNK1/2 (D-9): sc-137019 monoclonal antibody?

Asked by: Randy McDonald
Thank you for your question. We recommend this antibody for use in denatured Western Blot conditions. It has not been validated for use in non-denatured conditions. Please contact our Technical Service Department for further details or inquiries.
Answered by: Technical Support
Date published: 2017-02-27
  • y_2026, m_11, d_5, h_5CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_137019, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 102ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by SS from Performs well in WesternPerforms well in Western, good specificity in RAW 264.7 whole cell lysate. -SCBT QC
Date published: 2015-04-28
Rated 5 out of 5 by TS from Single strong band for WB in human recombinantSingle strong band for WB in human recombinant JNK1. -SCBT QC
Date published: 2013-02-20
  • y_2026, m_11, d_5, h_5
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_137019, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT
JNK1/2 Antibody (D-9) is rated 5.0 out of 5 by 2.
  • y_2026, m_11, d_5, h_5
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_137019, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 95ms
  • REVIEWS, PRODUCT